Related Experiment Video
Updated: Apr 28, 2026

Immunofluorescence to Monitor the Cellular Uptake of Human Lactoferrin and its Associated Antiviral Activity Against the Hepatitis C Virus
Published on: October 1, 2015
Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection
Melissa E Laird1, Amira Mohsen2, Darragh Duffy1
1Laboratory of Dendritic Cell Immunobiology, Institut Pasteur, Paris, France; INSERM U818, Paris, France.
Insights
Hepatitis C virus (HCV) clearance is linked to higher levels of apolipoprotein H (ApoH). This novel host factor, ApoH, interacts with IL28B genetic variants, influencing treatment response and viral clearance.
Area of Science:
- Hepatology
- Virology
- Immunogenetics
Background:
- Hepatitis C virus (HCV) replication depends on host lipid metabolism.
- Apolipoproteins are crucial in the host response to HCV infection and treatment.
Purpose of the Study:
- To investigate plasma apolipoprotein concentrations in patients with acute and chronic Hepatitis C virus (HCV) infection.
- To evaluate the association between apolipoproteins and IL28B polymorphisms in relation to HCV clearance.
Main Methods:
- Plasma apolipoprotein levels were measured in three patient cohorts: acute HCV, chronic HCV undergoing treatment, and HIV/HCV co-infected patients.
- Associations between apolipoproteins, IL28B polymorphisms (rs12979860 CC SNP), and HCV clearance were analyzed.
Main Results:
- Higher plasma apolipoprotein H (ApoH) levels were observed in patients achieving spontaneous or treatment-induced HCV clearance.
- ApoH levels correlated with the IL28B rs12979860 CC single nucleotide polymorphism (SNP) across all cohorts.
- Both ApoH and IL28B CC SNP were independently associated with HCV clearance, suggesting a shared biological pathway.
Conclusions:
- Apolipoprotein H (ApoH) is identified as the first protein quantitative trait associated with IL28B genetic variants.
- ApoH represents a novel host factor influencing Hepatitis C virus (HCV) clearance, potentially mediated by IL28B allele-dependent mechanisms.
Background & Aims:
HCV requires host lipid metabolism for replication, and apolipoproteins have been implicated in the response to treatment.
Methods:
We examined plasma apolipoprotein concentrations in three cohorts of patients: mono-infected patients with symptomatic acute hepatitis C (aHCV); those undergoing treatment for chronic hepatitis C (cHCV); and HIV/HCV co-infected patients being treated for their chronic hepatitis C. We also evaluated associations between apolipoproteins and IL28B polymorphisms, a defined genetic determinant of viral clearance.
Results:
Plasma apolipoprotein H (ApoH) levels were significantly higher in patients who achieved spontaneous clearance or responded to pegylated-interferon/ribavirin therapy. Strikingly, patients carrying the IL28B rs12979860 CC SNP correlated with the plasma concentration of ApoH in all three cohorts. Both ApoH and IL28B CC SNP were associated with HCV clearance in univariate analysis. Additional multivariate analysis revealed that the association between IL28B and HCV clearance was closely linked to that of Apo H and HCV clearance, suggesting that both belong to the same biological pathway to clearance. The association between IL28B CC SNP and ApoH was not observed in healthy individuals, suggesting that early post-infection events trigger differential ApoH expression in an IL28B allele dependent manner.
Conclusions:
This relationship identifies ApoH as the first induced protein quantitative trait associated with IL28B, and characterises a novel host factor implicated in HCV clearance.
More Related Videos
Related Concept Videos
Hepatitis
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

